Neuroactive steroids reduced spontaneous seizures and hyperthermia-induced seizures and prolonged survival in an Scn1a+/− mouse model of Dravet syndrome [103]. This evidence concerns the gene SCN1A and encephalopathy, progressive, early-onset, with brain edema and/or leukoencephalopathy.